Explore the science, products and technologies behind Concept Medical Group. One mobile-first destination for healthcare professionals and professional audiences at every conference.
See the Science.
Explore the Portfolio.
Discover the Group.
From SirPAD / NEJM evidence to Nanolute technology and Envision Scientific manufacturing — a smarter way to explore Concept Medical Group at conference.
Landmark clinical evidence from SirPAD, SIRONA, EASTBOURNE and TRANSFORM II supporting the MagicTouch platform across PAD and coronary artery disease.
Prospective all-comer registry evaluating MagicTouch SCB across a broad coronary lesion spectrum, including ISR, small vessels and bifurcations.
One of the largest global DCB RCTs — 1,832 patients across 52 centres. Primary endpoint: TLF at 12 months. Enrollment completed June 2025.
Landmark RCT confirming safety and efficacy of MagicTouch PTA sirolimus-coated balloon in PAD. Primary endpoint met and published in the New England Journal of Medicine.
World's only head-to-head RCT — Sirolimus vs Paclitaxel DCB in SFA. MagicTouch PTA demonstrated statistically significant superiority for freedom from cd-TLR at 36 months.
p=0.03
p=0.61
p=0.67
Explore the full Concept Medical Group portfolio across coronary, peripheral, access and specialty use cases.
World's first Sirolimus Coated Balloon for targeted sub-micron drug delivery across the CAD spectrum. Indicated for ISR, small vessels, bifurcation and de-novo lesions. 2 US FDA IDE Approvals for Small Vessels & In-Stent Restenosis.
View product →Sirolimus-coated balloon for stenotic lesions of dysfunctional AV fistula and graft. Dedicated clinical trials and investigator programme for dialysis access patients.
View product →Sirolimus-coated balloon for vasculogenic erectile dysfunction in de-novo and restenotic lesions. A specialty innovation extending the MagicTouch platform.
View product →Peripheral sirolimus-coated balloon for SFA, BTK, popliteal and iliac arteries. SirPAD primary results published in NEJM 2026 confirming safety and efficacy in PAD.
View product →Sirolimus-eluting stent for diabetes mellitus, acute myocardial infarction and symptomatic CAD. Powered by the Envisolution platform for better bioavailability and long-term outcomes.
View product →Polymer-free sirolimus-eluting stent with fusion-coating. Active STARS DAPT programme with first patient enrolled January 2026. Designed for reduced DAPT duration and improved healing.
View product →Broad peripheral angioplasty solution including SFA, BTK and AV dialysis fistulae. Designed as a reliable adjunct dilatation device for complex peripheral and access workflows.
View product →Rapid exchange thrombus aspiration catheter for central and peripheral circulatory use in PTCA, PTA and stenting procedures. Adjunct support across multiple indications.
View product →Drug-delivery platforms connecting clinical intent with precise drug transfer, retention and healing behaviour.
Sub-micron sirolimus nanoparticles in a proprietary excipient matrix — enabling uniform drug distribution, controlled transfer kinetics and 100% circumferential surface coverage across all MagicTouch DCB products.
Explore Nanolute™ →Nano-composite polymer matrix engineered for controlled sirolimus elution over an extended duration — promoting vessel healing, reducing inflammatory response and improving biocompatibility across the Abluminus DES family.
Explore Envisolution™ →Manufacturing scale, quality systems and controlled facility access underpinning the Concept Medical Group portfolio.
Manufacturing establishment behind Concept Medical Group responsible for production scale, quality systems, regulatory compliance and controlled facility operations across DCB and DES product families.
12-hour or 24-hour time-limited virtual access to the manufacturing environment for registered professional visitors attending this conference.
Register interest in Concept Classroom, download product documentation, or explore Concept Life — the companion app for HCPs.
An education-first format connecting science, technique and applied learning for healthcare professionals. Register interest to receive updates at launch.
Access clinical updates, product brochures and approved publications for MagicTouch and Abluminus families.
The official Concept Medical companion app for healthcare professionals. Stay up to date with the latest clinical data, product information, trial updates and educational content — all in one place. Available on iOS and Android.
Book a meeting, reach medical information or connect with the right representative for your region.
Meet a Concept Medical representative at the conference or schedule a follow-up session post-event.
Reach the Concept Medical team directly for product queries, medical information or documentation requests.
Connect directly with our team for product details, clinical questions, or to be put in touch with the right person in your region.
An education-first format connecting science, technique and applied learning for healthcare professionals. Register your interest to be the first to know when Concept Classroom launches.